The benefits of PRRT are numerous, particularly for patients with advanced or metastatic neuroendocrine tumors. These include:
- Targeted Treatment: PRRT specifically targets cancer cells, minimizing damage to healthy tissues. - Effectiveness: Clinical studies have shown significant improvement in progression-free survival and overall survival in patients treated with PRRT. - Symptom Relief: Many patients experience relief from symptoms related to hormone secretion by NETs. - Quality of Life: The targeted nature of the therapy often results in fewer side effects compared to conventional systemic therapies, thereby improving the patient's quality of life.
